Cargando…
Ethyl Acetate Extract from Artemisia argyi Prevents Liver Damage in ConA-Induced Immunological Liver Injury Mice via Bax/Bcl-2 and TLR4/MyD88/NF-κB Signaling Pathways
Background: Immunological liver injury (ILI) is a common liver disease and lacks potent drugs for treatment. Artemisia argyi Lévl. et Vant. (A. argyi), a medicinal and edible homologous plant usually used in diet therapy to cure various liver diseases, provides a great option for the prevention of I...
Autores principales: | Yang, Wenqian, Shao, Fei, Wang, Jiexin, Shen, Tong, Zhao, Yu, Fu, Xueyan, Zhang, Liming, Li, Hangying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693258/ https://www.ncbi.nlm.nih.gov/pubmed/36431983 http://dx.doi.org/10.3390/molecules27227883 |
Ejemplares similares
-
Hepatic MyD88 regulates liver inflammation by altering synthesis of oxysterols
por: Lefort, Charlotte, et al.
Publicado: (2019) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022) -
A MyD88 meddles with survival
por: Bashyam, Hema
Publicado: (2007) -
Role of MyD88 in Adenovirus Keratitis
por: Zhou, Xiaohong, et al.
Publicado: (2016)